Abstract: Involved is an isolated antigen binding protein, being capable of binding CCR8 derived from a primate animal. Further involved are a pharmaceutical composition comprising the antigen binding protein, and an application of the antigen binding protein and/or the pharmaceutical composition in the prevention and/or treatment of a tumor or a cancer.

Abstract: In some embodiments, a method receives a first sequence of inputs for processing via a sub-model of a plurality of sub-model. The plurality of sub-models are part of a main model. An input in the sequence of inputs is masked with a masked value to generate a second sequence of inputs. The method processes the second sequence of inputs using the sub-model to generate a sequence of features that correspond to the second sequence of inputs and processes the sequence of features to generate a first output. The first output is processed to generate a second output of the main model. The sub-model is trained based on a feature in the sequence of features that corresponds to the masked input and the second output.

Abstract: A conversion power supply and an autonomous electric energy replenishment method for an energy storage system are provided. An output terminal of the power supply module is connected to a second side of a first DC-DC converter through an energy storage element. A first side of the first DC-DC converter is connected to battery clusters of the energy storage system through a DC interface of the conversion power supply, so that under control by a conversion power supply controller, in a case that a voltage of a battery cluster is lower than a preset threshold, the first DC-DC converter receives the electric energy on the second side, and transmit the electric energy to the first side of the first DC-DC converter, to realize a electric energy replenishment function for at least one of the battery clusters and prevent battery failure due to over-discharge.

Abstract: A glass panel and silicon wafer separation device for photovoltaic module recovery includes a tank body, a supporting plate and at least two floating blocks. The supporting plate is positioned in the tank body. A vertically arranged first cylinder is arranged at a lower end of the tank body. An output end of the first cylinder is fixedly connected to a lower end of the supporting plate. A groove is formed in an upper end of the supporting plate, and the groove is matched with a photovoltaic plate. A heating block is mounted at a lower end of an inner wall of the tank body. The at least two floating blocks are columnar. Lower ends of the at least two floating blocks are fixedly connected to chucks, and the chucks are downwards opened. Fixed pipes are connected between the at least two floating blocks.

Abstract: Disclosed are a decoquinate liposome, a preparation method therefor and a use thereof. The preparation raw materials for the decoquinate liposome comprise the following components in parts by weight: 1 part of decoquinate and 2-20 parts of lecithin. The liposome is stable, shows favorable malaria resistance effects in-vivo and in-vitro with respect to animal bodies, can be used for quickly relieving the conditions of malaria, particularly subtertian malaria, and is safe. The preparation method is simple and feasible, and has the potential for mass production.

Abstract: The disclosure relates to a method performed by an electronic device of a base station. The method includes: obtaining beam priority information of a plurality of beams for a plurality of user equipments (UEs); obtaining inter-beam interference information of the plurality of beams; identifying, based on the beam priority information and the inter-beam interference information, one of a plurality of beam pairing sets comprising two or more beams among the plurality of beams; and performing communication with at least one of the plurality of UEs via the identified beam pairing set.

Abstract: A heating treatment device for photovoltaic module recycling includes a box, a heating rod and a gas pump. A horizontal partition is fixedly arranged inside the box, and the heating rod is located below the partition. The partition is provided with evenly distributed second through slots. An upper end of the partition is provided with evenly distributed shelf boards. The shelf boards are arranged vertically. One side of the shelf board is provided with a groove. The shelf board is further provided with a suction cup. An end surface at an opening of the suction cup is flush with an inner wall of the groove. The movable splitting sheets are arranged in the device. A lower end of the splitting sheet is provided with gas vents, and hot air is discharged through the gas vents. The temperature of the hot air is controlled at 220-240° C.

Abstract: A pyrolysis apparatus for completely separating an EVA crystal silicon wafer from a waste photovoltaic module includes a heating mechanism controlled by a control system and mounted in a pyrolysis box and being capable of performing telescopic motion in a vertical direction; an overturning assembly for fixedly clamping and driving a photovoltaic module to overturn, the overturning assembly is arranged just under the heating mechanism; and a splitting assembly for separating the photovoltaic module, the splitting assembly is arranged at a left side of the photovoltaic module fixedly clamped by the overturning assembly. A splitting apparatus is provided for assisting in splitting EVA, and isolating glass from the crystal silicon wafer, as well as isolating a back plate from the crystal silicon wafer, and therefore, the pressure generated on the crystal silicon wafer due to large strength of the glass and shrinkage of the back plate is prevented.

Abstract: The present invention relates to use of gTso thal in manufacturing a medicament for the promotion of MS-275 to cross the blood-brain barrier (BBB), and belongs to the technical field of pharmaceutical preparation. Administration of the medicament manufactured by the use of the present invention in combination with MS-275 significantly increases MS-275 to cross the BBB into the brain tissue, and prominently promotes the accumulation of MS-275 therein.

Abstract: The present disclosure relates to methods and apparatuses for processing an image, training an image recognition network and recognizing an image. The method of processing an image includes: obtaining a plurality of original images from an original image set, where at least one of the plurality of original images includes an annotation area; obtaining at least one first image by splicing the plurality of original images; for each of the at least one first image, adjusting a shape and/or size of the first image based on the plurality of original images to form a second image; obtaining respective positions of the at least one annotation area in the second image by converting respective positions of the at least one annotation area in the plurality of original images.

Abstract: The invention provides a thin film deposition system and a method, and relates to the field of thin film deposition. The deposition method comprises the following steps: 1) heating metal substrate; carrying out deposition. The method is characterized in the step 1) that a current is conducted into the metal substrate at one end of the growth zone by one electrode, and out of the metal substrate at the other end of the growth zone by the other electrode, so that the metal substrate is heated by the heat emitting of the resistant of the metal substrate itself. According to the method, the quality of the prepared thin film is improved, while the preparation cost of the thin film is reduced. In addition, the consistent double-sided thin films can be easily prepared on two surfaces of the metal substrate by employing the system and method.

Abstract: The present invention relates to use of gTso thal in manufacturing a medicament for the promotion of MS-275 to cross the blood-brain barrier (BBB), and belongs to the technical field of pharmaceutical preparation. Administration of the medicament manufactured by the use of the present invention in combination with MS-275 significantly increases MS-275 to cross the BBB into the brain tissue, and prominently promotes the accumulation of the medicament therein.

Abstract: A tile, a tile assembly and a method of fabricating a tile are provided. The tile includes: an arc-shaped tile body including a first end and a second end in its length direction; and an arc-shaped jacket including a fixing section and a mounting section sequentially disposed in its length direction, a convex side surface of the fixing section is attached and fixed to a concave side surface of the first end of the tile body, the mounting section protrudes from an end surface of the first end of the tile body, and a convex side surface of the mounting section can be attached to a concave side surface of the second end of the tile body of another tile, the convex side surface of the jacket is provided with a drainage groove between the fixing section and the mounting section and extending along a width direction of the jacket.

Abstract: The invention provides a thin film deposition system and a method, and relates to the field of thin film deposition. The deposition method comprises the following steps: 1) heating metal substrate; carrying out deposition. The method is characterized in the step 1) that a current is conducted into the metal substrate at one end of the growth zone by one electrode, and out of the metal substrate at the other end of the growth zone by the other electrode, so that the metal substrate is heated by the heat emitting of the resistant of the metal substrate itself. According to the method, the quality of the prepared thin film is improved, while the preparation cost of the thin film is reduced. In addition, the consistent double-sided thin films can be easily prepared on two surfaces of the metal substrate by employing the system and method.

Abstract: The invention provides a thin film deposition system and a method, and relates to the field of thin film deposition. The deposition method comprises the following steps: 1) heating metal substrate; carrying out deposition. The method is characterized in the step 1) that a current is conducted into the metal substrate at one end of the growth zone by one electrode, and out of the metal substrate at the other end of the growth zone by the other electrode, so that the metal substrate is heated by the heat emitting of the resistant of the metal substrate itself. According to the method, the quality of the prepared thin film is improved, while the preparation cost of the thin film is reduced. In addition, the consistent double-sided thin films can be easily prepared on two surfaces of the metal substrate by employing the system and method.

Abstract: The invention provides a thin film deposition system and a method, and relates to the field of thin film deposition. The deposition method comprises the following steps: 1) heating metal substrate; carrying out deposition. The method is characterized in the step 1) that a current is conducted into the metal substrate at one end of the growth zone by one electrode, and out of the metal substrate at the other end of the growth zone by the other electrode, so that the metal substrate is heated by the heat emitting of the resistant of the metal substrate itself. According to the method, the quality of the prepared thin film is improved, while the preparation cost of the thin film is reduced. In addition, the consistent double-sided thin films can be easily prepared on two surfaces of the metal substrate by employing the system and method.

Abstract: Disclosed herein are isolated polypeptides, antibody preparations, treatment methods, diagnostic methods, and screening methods related to tauopathy. Generally, the isolated polypeptide includes a core pentapeptide, with the proviso that the isolated polypeptide is not a native full-length tau protein. Generally, the antibody preparations include antibody that specifically binds to SEQ ID NO:12. Generally, the treatment methods include administering to a subject a composition that includes the isolated polypeptide. Generally, the diagnostic methods includes contacting a sample from a subject with an antibody preparation that includes antibody that specifically binds to SEQ ID NO:12, and then detecting a ligand in the sample that specifically binds the antibody preparation.

Abstract: Disclosed herein are isolated polypeptides, antibody preparations, treatment methods, diagnostic methods, and screening methods related to tauopathy. Generally, the isolated polypeptide includes a core pentapeptide, with the proviso that the isolated polypeptide is not a native full-length tau protein. Generally, the antibody preparations include antibody that specifically binds to SEQ ID NO:12. Generally, the treatment methods include administering to a subject a composition that includes the isolated polypeptide. Generally, the diagnostic methods includes contacting a sample from a subject with an antibody preparation that includes antibody that specifically binds to SEQ ID NO:12, and then detecting a ligand in the sample that specifically binds the antibody preparation.